Related Experiment Videos

High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1

J Sundell1, T Rönnemaa, H Laine

  • 1Turku PET Centre, Turku University Central Hospital, P.O. Box 52, 20521 Turku, Finland. jan.sundell@utu.fi

Diabetologia
|November 27, 2004
PubMed

Insights

In type 1 diabetes, elevated high-sensitivity C-reactive protein (hsCRP) is linked to reduced coronary vasoreactivity, even at slightly increased levels. This finding highlights hsCRP as a potential marker for cardiovascular risk in diabetic individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Immunology

Background:

  • Elevated high-sensitivity C-reactive protein (hsCRP) is a known risk factor for future coronary events.
  • The relationship between hsCRP and coronary vasoreactivity in type 1 diabetes remains unexamined.

Purpose of the Study:

  • To investigate the association between hsCRP concentrations and coronary vasoreactivity in young individuals with type 1 diabetes.
  • To determine if hsCRP levels correlate with impaired blood flow regulation in the coronary arteries of diabetic subjects.

Main Methods:

  • Study included 18 young men with uncomplicated type 1 diabetes, divided into high and low hsCRP groups, and 22 age-matched controls.
  • Myocardial blood flow at rest and during adenosine stimulation was measured using positron emission tomography (PET) with oxygen-(15)-labelled water.
  • Euglycaemic-hyperinsulinaemic clamp was employed to assess flow dynamics.

Main Results:

  • Diabetic subjects with slightly elevated hsCRP showed significantly higher hsCRP levels compared to non-diabetic controls.
  • Resting myocardial blood flow was comparable across all groups.
  • Adenosine-stimulated coronary blood flow was significantly blunted in diabetic subjects with slightly elevated hsCRP compared to both low hsCRP diabetics and non-diabetic controls.
  • A significant inverse correlation was found between hsCRP concentrations and adenosine-stimulated flow in all diabetic subjects (r=-0.70, p=0.001).

Conclusions:

  • Even slightly elevated hsCRP concentrations are associated with reduced coronary vasoreactivity in young individuals with uncomplicated type 1 diabetes.
  • hsCRP may serve as an early indicator of endothelial dysfunction and increased cardiovascular risk in this population.
  • Further research is warranted to explore the mechanisms linking hsCRP to impaired vasoreactivity in type 1 diabetes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...